Stay updated on Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision history updated: added v3.4.2 and removed v3.4.1.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision: v3.4.1 was added to the history. The Notice about government funding and operating status was removed.SummaryDifference0.7%

- Check22 days agoChange DetectedA site-wide notice banner about a lapse in government funding and the NIH Clinical Center's operating status was added at the top of the page. The banner is informational and does not modify core trial data or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check29 days agoChange DetectedThe update adds a glossary display and color-coded highlights for additions (green) and deletions (red) in the study history, and updates the revision label to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check37 days agoChange DetectedRecord History now includes a new revision entry v3.3.4 and removes v3.3.3. This is a minor administrative update to the revision history.SummaryDifference0.1%

- Check58 days agoChange DetectedAdverse Events, Participant Flow, Document Section, and Study Status sections were added to the Record History. New version entries reflect updates on 2025-12-04 and 2025-12-23.SummaryDifference0.7%

Stay in the know with updates to Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Lenvatinib in Advanced Melanoma Clinical Trial page.